The Pathophysiology of Shock in Anaphylaxis

Immunology and Allergy Clinics of North America

Volumn 27, Issue 2, 2007, Pages 165-175

  Brown, Simon G A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMRINONE; ANTIHISTAMINIC AGENT; ATROPINE; GLUCAGON; METARAMINOL; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASOCONSTRICTOR AGENT; VASOPRESSIN;

ANAPHYLACTIC SHOCK; BRADYCARDIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; EXTRAVASATION; FLUID RESUSCITATION; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HUMAN; HYPOVOLEMIC SHOCK; NONHUMAN; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; VEIN TONE; VENOUS RETURN;

ANAPHYLAXIS; ANIMALS; HUMANS; SHOCK;

EID: 34247623532     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.03.003     Document Type: Review

References (54)

1. Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30 8 (2000) 1144-1150
2. Brown S.G.A. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114 2 (2004) 371-376
3. Weil M.H. Personal commentary on the diagnosis and treatment of circulatory shock states. Curr Opin Crit Care 10 4 (2004) 246-249
4. Beaupre P.N., Roizen M.F., Cahalan M.K., et al. Hemodynamic and two-dimensional transesophageal echocardiographic analysis of an anaphylactic reaction in a human. Anesthesiology 60 5 (1984) 482-484
5. Fisher M. Blood volume replacement in acute anaphylactic cardiovascular collapse related to anaesthesia. Br J Anaesth 49 10 (1977) 1023-1026
6. Fisher M.M. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 14 1 (1986) 17-21
7. Heytman M., and Rainbird A. Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review. Anaesthesia 59 12 (2004) 1210-1215
8. Schummer W., Schummer C., Wippermann J., et al. Anaphylactic shock: is vasopressin the drug of choice?. Anesthesiology 101 4 (2004) 1025-1027
9. Kill C., Wranze E., and Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 134 3 (2004) 260-261
10. Hanashiro P.K., and Weil M.H. Anaphylactic shock in man. Report of two cases with detailed hemodynamic and metabolic studies. Arch Intern Med 119 2 (1967) 129-140
11. Raper R.F., and Fisher M.M. Profound reversible myocardial depression after anaphylaxis. Lancet 1 8582 (1988) 386-388
12. Brown S.G.A., Blackman K.E., Stenlake V., et al. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 21 2 (2004) 149-154
13. Silverman H.J., Van Hook C., and Haponik E.F. Hemodynamic changes in human anaphylaxis. Am J Med 77 2 (1984) 341-344
14. Silverman H.J., Taylor W.R., Smith P.L., et al. Effects of antihistamines on the cardiopulmonary changes due to canine anaphylaxis. J Appl Physiol 64 1 (1988) 210-217
15. Pavek K. Anaphylactic shock in the monkey: its hemodynamics and mediators. Acta Anaesthesiol Scand 21 4 (1977) 293-307
16. Patterson R., Fink J.N., Wennemark J., et al. The biologic consequences of the immediate-type hypersensitivity transferred from man to monkey. J Allergy 37 5 (1966) 295-310
17. Melli G., Folli G., Mazzei D., et al. Shock organ and shock tissue in various animal species. Acta Allergol 18 (1963) 188-210
18. Auer J., and Lewis P.A. Physiology of the immediate reaction of anaphylaxis in the guinea pig. J Exp Med 12 (1910) 151-175
19. Criep L.H. Electrocardiographic studies of the effects of anaphylaxis on the cardiac mechanism. Arch Intern Med 48 (1931) 1098-1108
20. Felix S.B., Baumann G., and Berdel W.E. Systemic anaphylaxis-separation of cardiac reactions from respiratory and peripheral vascular events. Res Exp Med (Berl) 190 4 (1990) 239-252
21. Capurro N., and Levi R. The heart as a target organ in systemic allergic reactions: comparison of cardiac anaphylaxis in vivo and in vitro. Circ Res 36 4 (1975) 520-528
22. Regal J.F., and Heller L.J. Cardiac anaphylaxis in isolated guinea pig hearts perfused at constant flow or constant pressure. Proc Soc Exp Biol Med 185 2 (1987) 193-200
23. Mink S., Becker A., Sharma S., et al. Role of autacoids in cardiovascular collapse in anaphylactic shock in anaesthetized dogs. Cardiovasc Res 43 1 (1999) 173-182
24. Mink S.N., Bands C., Becker A., et al. Effect of bolus epinephrine on systemic hemodynamics in canine anaphylactic shock. Cardiovasc Res 40 3 (1998) 546-556
25. Mink S.N., Becker A., Unruh H., et al. Effects of anaphylaxis mediators on partitioned pulmonary vascular resistance during ragweed shock in dogs. J Appl Physiol 84 3 (1998) 782-790
26. Mink S.N., Simons F.E., Simons K.J., et al. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin Exp Allergy 34 11 (2004) 1776-1783
27. Smith P.L., Kagey-Sobotka A., Bleecker E.R., et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 66 5 (1980) 1072-1080
28. Zaloga G.P., DeLacey W., Holmboe E., et al. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 105 1 (1986) 65-66
29. Otero E., Onufer J.R., Reiss C.K., et al. Anaphylaxis-induced myocardial depression treated with amrinone. Lancet 337 8742 (1991) 682
30. Fisher M. Treating anaphylaxis with sympathomimetic drugs. BMJ 305 6862 (1992) 1107-1108
31. Cooper D.J. Cardiac dysfunction during anaphylaxis in patients. Appl Cardiopulm Pathophysiol 5 (1993) 9-18
32. Marone G., Bova M., Detoraki A., et al. The human heart as a shock organ in anaphylaxis. Novartis Found Symp 257 (2004) 133-149 [discussion: 149-60, 276-85]
33. Patella V., de Crescenzo G., Ciccarelli A., et al. Human heart mast cells: a definitive case of mast cell heterogeneity. Int Arch Allergy Immunol 106 4 (1995) 386-393
34. Patella V., Genovese A., and Marone G. What are human heart mast cells for?. Chem Immunol 62 (1995) 171-186
35. Patella V., Marino I., Lamparter B., et al. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 154 6 (1995) 2855-2865
36. Austin S.M., Barooah B., and Kim C.S. Reversible acute cardiac injury during cefoxitin-induced anaphylaxis in a patient with normal coronary arteries. Am J Med 77 4 (1984) 729-732
37. Levine H.D. Acute myocardial infarction following wasp sting. Report of two cases and critical survey of the literature. Am Heart J 91 3 (1976) 365-374
38. Quercia O., Rafanelli S., Emiliani F., et al. Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction. Allerg Immunol (Paris) 35 2 (2003) 61-63
39. Wittstein I.S., Thiemann D.R., Lima J.A., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352 6 (2005) 539-548
40. Soufras G.D., Ginopoulos P.V., Papadaki P.J., et al. Penicillin allergy in cancer patients manifesting as Kounis syndrome. Heart Vessels 20 4 (2005) 159-163
41. Koutsojannis C.M., and Kounis N.G. Lepirudin anaphylaxis and Kounis syndrome. Circulation 109 22 (2004) e315 author reply e315
42. Kounis N.G., Grapsas N.D., and Goudevenos J.A. Unstable angina, allergic angina, and allergic myocardial infarction. Circulation 100 25 (1999) e156
43. Brown S.G.A., Wiese M.D., Blackman K.E., et al. Ant venom immunotherapy: a double-blind, placebo-controlled, cross-over trial. Lancet 361 9362 (2003) 1001-1006
44. Szebeni J., Baranyi L., Savay S., et al. Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function. Am J Physiol Heart Circ Physiol 290 3 (2006) H1050-H1058
45. Demetriades D., Chan L.S., Bhasin P., et al. Relative bradycardia in patients with traumatic hypotension. J Trauma 45 3 (1998) 534-539
46. Schadt J.C., and Ludbrook J. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. Am J Physiol 260 2 Pt 2 (1991) H305-H318
47. Kasperska-Zajac A., and Rogala B. Platelet function in anaphylaxis. J Investig Allergol Clin Immunol 16 1 (2006) 1-4
48. Cauwels A., Janssen B., Buys E., et al. Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 116 8 (2006) 2244-2251
49. Lowenstein C.J., and Michel T. What's in a name? eNOS and anaphylactic shock. J Clin Invest 116 8 (2006) 2075-2078
50. Choi I.W., Kim Y.S., Kim D.K., et al. Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction. J Exp Med 198 1 (2003) 145-151
51. Brown S.G.A. Anaphylaxis: clinical concepts and research priorities. Emerg Med Australas 18 2 (2006) 155-169
52. Pumphrey R.S. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112 2 (2003) 451-452
53. Andjelkovic I., and Zlokovic B. Protective effects of glucagon during the anaphylactic response in guinea pig isolated heart. Br J Pharmacol 76 3 (1982) 483-489
54. Thomas M., and Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta blockers. Emerg Med J 22 4 (2005) 272-273